IRCT20200506047325N1尚未招募未知
Investigation of antihypertensive effect of antioxidant enriched Ziziphus jujuba fruit extract in patients with primary hypertension: A randomized, double-blind, placebo controlled clinical trial
Golestan University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- Female
入选标准
- •120 mmHg < blood pressure < mmHg 160 (Pre- and stage 1 hypertension)
- •Age over 18, female or male
- •Voluntary participation and written consent
排除标准
- •Other heart diseases
- •Secondary blood pressure
- •Serum Potassium > 5.5 mmol/L or < 3.5 mmol/L
- •double serum creatinine in the last 6 months
- •Severe complications of diabetes or serious macrovascular events within 6 months (for example, cerebral hemorrhage, cerebral infarction, or acute myocardial infarction)
- •Recent infection in the last 4 weeks
- •Primary or secondary kidney disease (e.g., IgA nephropathy, membranous nephropathy, or lupus nephritis)
- •Any cancer and malignancy
- •Severe mental disorder
- •Pregnant or lactating women or women who are planning to become pregnant or women who are not using appropriate contraceptive methods
- •Drug allergies or jujube allergies
- •Participate in other clinical trials
- •Use of other herbal medicines to control the symptoms of the present disease
- •History of smoking, drugs
- •Other conditions that the researchers considered inappropriate in this clinical study
研究者
相似试验
已完成
不适用
An antihypertensive intervention trial to lower blood pressure in untreated hypertensive patients based on the gene polymorphisms in the pathway of the drug-metabolism and biological effectsCardiovascular - HypertensionHypertensionACTRN12607000108415Cardiovascular Institute, Chinese Academy of Medical Sciences4,000
已完成
不适用
EVALUATION OF ANTIHYPERTENSIVE EFFECTS OF FREQUENT thermoneutral BATHS, A RANDOMIZED CONTROLLED TRIAI10.0DRKS00003980niversitätsklinikum Freiburg59
已完成
不适用
Assessment of the Effect of Anti-hypertensive Medication on Central Blood Pressure Using Home BP deviceHypertensionJPRN-UMIN000005655The Second Department of Internal Medicine Tokyo Medical University100
进行中（未招募）
1 期
Effetto antipertensivo di differenti dosi del Rostafuroxin in confronto con Losartan, valutato con Rilevazioni Pressorie Ambulatoriali e Monitoraggio Pressorio nelle 24 ore in pazienti ipertesi portatori di uno specifico profilo genetico.Patients with arterial hypertension, bearers of a specific genetic profile (Presence of at least one mutated genotype or combination of genotypes corresponding to the list provided in Genetic Profile 1).MedDRA version: 20.0 Level: SOC Classification code 10007541 Term: Cardiac disorders System Organ Class: 10007541 - Cardiac disordersEUCTR2010-022073-34-ITCVIE THERAPEUTICS COMPANY LIMITED280
已完成
4 期
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochrolthiazide in hypertemnsive patientsJPRN-UMIN000000798on profit Organization LINE60